Finasteride boosts PSA ability to detect prostate cancer

August 22, 2006

The medication finasteride, which after the seven-year Prostate Cancer Prevention Trial (PCPT) was associated with a 24.8 percent reduction of prostate cancer risk among men who took it, has a new feather in its cap – it beefs up the diagnostic power of the prostate-specific antigen (PSA) test.




Director of the San Antonio Cancer Institute appointed

July 25, 2006

William Henrich, M.D., M.A.C.P., dean of the Health Science Center’s School of Medicine and vice president for medical affairs, and Karen Fields, M.D., president and CEO at the Cancer Therapy and Research Center (CTRC), are pleased to announce that the Health Science Center and the CTRC have jointly recruited one of the nation’s outstanding oncologists, Tyler Curiel, M.D., to lead the San Antonio Cancer Institute (SACI).


RAHC expansion is ‘a commitment to the people of the Valley’

July 25, 2006

Francisco G. Cigarroa, M.D., president of the Health Science Center, told Lower Rio Grande Valley leaders July 17 that the Regional Academic Health Center’s second Harlingen building, currently under construction, represents “a firm and enduring commitment by the Health Science Center to the people of the Lower Rio Grande Valley, chief among them our veterans.”